Biotec Pharmacon ASA, together with its subsidiaries, develops, manufactures, and markets immune modulating compounds for the human health sectors and marine enzymes in Norway. It is involved in the research on products to prevent or treat diseases caused by failure, imbalance, and over-reaction of the immune system. The company manufactures and sells beta-1,3/1,6-glucan products that are used as health promoting dietary supplements; and as active ingredient in cosmetics. It offers Woulgan Biogel, an advanced wound healing dressing contains an ancillary medicinal substance: and soluble beta-glucan. The company also supplies cold adapted and heat labile enzymes with properties for molecular biology research and PCR based diagnostics to international research reagents and diagnostics companies. Biotec Pharmacon ASA was founded in 1990 and is based in Tromsø, Norway.
biotec pharmacon asa (BIOTEC:Oslo Bors)
Forskningsparken – The Science Park
Phone: 47 77 64 89 00
Fax: 47 77 64 89 01www.biotec.no
|No competitor information is available for BIOTEC.|
|View Industry Companies|
|Price/Cash Flow||--||Not Meaningful|
Sponsored Financial Commentaries
To contact BIOTEC PHARMACON ASA, please visit www.biotec.no. Company data is provided by Capital IQ. Please use this form to report any data issues.